Effectiveness of the online Acceptance and Commitment Therapy intervention "Embrace Pain" for cancer survivors with chronic painful chemotherapy-induced peripheral neuropathy: study protocol for a randomized controlled trial

Daniëlle L van de Graaf, Floortje Mols, Hester R Trompetter, Marije L van der Lee, Karlein M G Schreurs, Elin Børøsund, Lise Solberg Nes, Tom Smeets, Daniëlle L van de Graaf, Floortje Mols, Hester R Trompetter, Marije L van der Lee, Karlein M G Schreurs, Elin Børøsund, Lise Solberg Nes, Tom Smeets

Abstract

Background: About 30% of cancer survivors suffer from chemotherapy-induced peripheral neuropathy (CIPN) ≥6 months after completion of chemotherapy. This condition, for which treatment options are scarce, comes with limitations in daily life functioning and decreased quality of life. The current study examines the effectiveness of an online self-help intervention based on Acceptance and Commitment Therapy (ACT) in comparison to a waiting list condition (WLC) to deal with CIPN. In addition, it examines which factors moderate effects and to what extent the effects differ between guided and unguided ACT intervention.

Methods: A two-parallel, non-blinded randomized controlled trial (RCT) will be carried out. Adult cancer survivors who experience painful CIPN for at least 3 months and completed chemotherapy at least 6 months ago will be recruited (n=146). In the intervention condition, participants will follow an 8-week self-management course containing 6 modules regarding psychoeducation and ACT processes, including therapeutic email guidance. By means of text and experiential exercises, supplemented with illustrations, metaphors, and audio files, people will learn to carry out value-oriented activities in their daily life with pain. Participants will learn new ways of coping with pain, including reducing pain avoidance and increasing pain acceptance. Participants in the WLC will be invited to follow the intervention without therapeutic guidance 5 months after start. Pain interference is the primary outcome, while psychological distress, quality of life, CIPN symptom severity, pain intensity, psychological flexibility, mindfulness skills, values-based living, and pain catastrophizing will serve as secondary outcomes. All outcome measures will be evaluated at inclusion and baseline, early-intervention, mid-intervention, post-treatment, and 3- and 6-month post-treatment. Qualitative interviews will be conducted post-treatment regarding experiences, usage, usability, content fit, and satisfaction with the intervention.

Discussion: This study will provide valuable information on the effectiveness of an online self-help intervention based on ACT versus WLC for chronic painful CIPN patients.

Trial registration: ClinicalTrials.gov NCT05371158 . Registered on May 12, 2022.

Protocol version: version 1, 24-05-2022.

Keywords: Acceptance and Commitment Therapy; CIPN; Cancer survivors; Online; PROFILES registry; eHealth.

Conflict of interest statement

The authors declare that they have no competing interests.

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
Flowchart

References

    1. Heins M, Schellevis F, Rijken M, Van Der Hoek L, Korevaar J. Determinants of increased primary health care use in cancer survivors. J Clin Oncol. 2012;30(33):4155–4160.
    1. Hulvat MC. Cancer incidence and trends. Surg Clin North Am. 2020. 10.1016/j.suc.2020.01.002.
    1. Elferink MAG, Van Steenbergen LN, Krijnen P, Lemmens VEPP, Rutten HJ, Marijnen CAM, et al. Marked improvements in survival of patients with rectal cancer in the Netherlands following changes in therapy, 1989-2006. Eur J Cancer. 2010;46(8):1421–1429.
    1. Van Steenbergen LN, Lemmens VEPP, Rutten HJT, Wymenga ANM, Nortier JWR, Janssen-Heijnen MLG. Increased adjuvant treatment and improved survival in elderly stage III colon cancer patients in the Netherlands. Ann Oncol. 2012;23(11):2805–2811.
    1. Sukel MPP, van de Poll-Franse LV, Nieuwenhuijzen GAP, Vreugdenhil G, Herings RMC, Coebergh JWW, et al. Substantial increase in the use of adjuvant systemic treatment for early stage breast cancer reflects changes in guidelines in the period 1990-2006 in the southeastern Netherlands. Eur J Cancer. 2008;44(13):1846–1854.
    1. Signaleringscommissie Kanker van KWF Kankerbestrijding. Kanker in Nederland tot 2020. Trends en prognoses. 2011. Available from: . Cited 2020 May 26.
    1. Mols F, Beijers T, Vreugdenhil G, Van De Poll-Franse L. Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review. Support Care Cancer. 2014;22(8):2261–2269.
    1. Seretny M, Currie GL, Sena ES, Ramnarine S, Grant R, Macleod MR, et al. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain. 2014;155(12):2461–2470.
    1. Kannarkat G, Lasher E. Neurology DS-C opinion in, 2007 U. Neurologic complications of chemotherapy agents. Curr Opin Neurol. 2007;20:719–725.
    1. Quasthoff S, Hartung HP. Chemotherapy-induced peripheral neuropathy. J Neurol. 2002;249(1):9–17.
    1. Farquhar-Smith P. Chemotherapy-induced neuropathic pain. Curr Opin Support Palliat Care. 2011;5(1):1–7.
    1. Beijers AJM, Jongen JLM, Vreugdenhil G. Chemotherapy-induced neurotoxicity: The value of neuroprotective strategies. Neth J Med. 2012;70(1):18–25.
    1. Glendenning JL, Barbachano Y, Norman AR, Dearnaley DP, Horwich A, Huddart RA. Long-term neurologic and peripheral vascular toxicity after chemotherapy treatment of testicular cancer. Cancer. 2010;116(10):2322–2331.
    1. Bonhof CS, Mols F, Vos MC, Pijnenborg JMA, Boll D, Vreugdenhil G, et al. Course of chemotherapy-induced peripheral neuropathy and its impact on health-related quality of life among ovarian cancer patients: a longitudinal study. Gynecol Oncol. 2018;149(3):455–463.
    1. Eckhoff L, Knoop A, Jensen M, Cancer ME-EJ of, 2015 U Persistence of docetaxel-induced neuropathy and impact on quality of life among breast cancer survivors. Eur J Cancer. 2015;51:292–300.
    1. Bao T, Basal C, Seluzicki C, Li SQ, Seidman AD, Mao JJ. Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk. Breast Cancer Res Treat. 2016;159(2):327–333.
    1. Beijers AJM, Mols F, Vreugdenhil G. A systematic review on chronic oxaliplatin-induced peripheral neuropathy and the relation with oxaliplatin administration. Support Care Cancer. 2014;22(7):1999–2007.
    1. Tofthagen C, Donovan KA, Morgan MA, Shibata D, Yeh Y. Oxaliplatin-induced peripheral neuropathy’s effects on health-related quality of life of colorectal cancer survivors. Support Care Cancer. 2013;21:3307–3313.
    1. Tofthagen C. Patient perceptions associated with chemotherapy-induced peripheral neuropathy. Clin J Oncol Nurs. 2010;14(3):E22–E28.
    1. Mols F, Beijers AJM, Lemmens V, van den Hurk CJ, Vreugdenhil G, Van De Poll-Franse LV. Chemotherapy-induced neuropathy and its association with quality of life among 2-to 11-year colorectal cancer survivors: results from the population-based PROFILES registry development of an EORTC cancer survivorship assessment strategy View project LIVE. Artic J Clin Oncol. 2013;31(21):2699–2707.
    1. Bonhof CS, Van de Poll-Franse LV, de Hingh IH, Nefs G, Vreugdenhil G, Mols F. Association between peripheral neuropathy and sleep quality among colorectal cancer patients from diagnosis until 2-year follow-up: results from the PROFILES registry. J Cancer Surviv. 2021. 10.1007/s11764-021-01130-7.
    1. Bonhof CS, Trompetter HR, Vreugdenhil G, van de Poll-Franse LV, Mols F. Painful and non-painful chemotherapy-induced peripheral neuropathy and quality of life in colorectal cancer survivors: results from the population-based PROFILES registry. Support Care Cancer. 2020;28(12):5933–5941.
    1. Hulbert-Williams NJ, Storey L, Wilson KG. Psychological interventions for patients with cancer: psychological flexibility and the potential utility of Acceptance and Commitment Therapy. Eur J Cancer Care. 2015;24(1):15–27.
    1. Feros DL, Lane L, Ciarrochi J, Blackledge JT. Acceptance and Commitment Therapy (ACT) for improving the lives of cancer patients: a preliminary study. Psychooncology. 2013;22(2):459–464.
    1. Hayes SC, Luoma J, Bond FW, Masuda A, Lillis J. Acceptance and commitment therapy: Model, processes and outcomes. Behav Res Ther. 2006;44(1):1–25.
    1. McCracken LM, Vowles KE. Acceptance and commitment therapy and mindfulness for chronic pain model, process, and progress. Am Psychol. 2014;69(2):178.
    1. Knoerl R, Smith EML, Barton DL, Williams DA, Holden JE, Krauss JC, et al. Self-guided online cognitive behavioral strategies for chemotherapy-induced peripheral neuropathy: a multicenter, pilot, randomized, wait-list controlled trial. J Pain. 2018;19(4):382–394.
    1. Børøsund E, Mirkovic J, Clark M, Ehlers S, Andrykowski M, Bergland A, Westeng M, Solberg Nes L. A stress management app intervention for cancer survivors: design, development, and usability testing. JMIR Form Res. 2018;2(2):e19. 10.2196/formative.9954.
    1. Gainsbury S, Blaszczynski A. Online self-guided interventions for the treatment of problem gambling. Int Gambl Stud. 2011;11(3):289–308.
    1. Slev VN, Mistiaen P, Pasman HRW, Leeuw IMV, van Uden-Kraan CF, Francke AL. Effects of eHealth for patients and informal caregivers confronted with cancer: a meta-review. Int J Med Inform. 2016;87:54–67.
    1. McAlpine H, Joubert L, Martin-Sanchez F, Merolli M, Drummond KJ. A systematic review of types and efficacy of online interventions for cancer patients. Patient Educ Couns. 2015;98(3):283–295.
    1. Kuijpers W, Groen WG, Oldenburg HS, Wouters MW, Aaronson NK, van Harten WH. eHealth for breast cancer survivors: use, feasibility and impact of an interactive portal. JMIR Cancer. 2016;2(1):e3.
    1. Trompetter HR, Bohlmeijer ET, Veehof MM, Schreurs KMG. Internet-based guided self-help intervention for chronic pain based on Acceptance and Commitment Therapy: a randomized controlled trial. J Behav Med. 2015;38(1):66–80.
    1. Veehof MM, Trompetter HR, Bohlmeijer ET, Schreurs KMG. Acceptance-and mindfulness-based interventions for the treatment of chronic pain: a meta-analytic review. Cogn Behav Ther. 2016;45(1):5–31.
    1. Trompetter HR, Bohlmeijer ET, Lamers SMA, Schreurs KMG. Positive psychological wellbeing is required for online self-help acceptance and commitment therapy for chronic pain to be effective. Front Psychol. 2016;7:353.
    1. Lin J, Paganini S, Sander L, Lüking M, Ebert DD, Buhrman M, et al. An internet-based intervention for chronic pain: a three-arm randomized controlled study of the effectiveness of guided and unguided acceptance and commitment therapy. Dtsch Arztebl Int. 2017;114(41):681–688.
    1. Baumeister H, Reichler L, Munzinger M, Lin J. The impact of guidance on Internet-based mental health interventions — a systematic review. Internet Interv. 2014;1(4):205–215.
    1. van de Poll-Franse LV, Horevoorts N, Schoormans D, Beijer S, Ezendam NPM, Husson O, et al. Measuring clinical, biological, and behavioral variables to elucidate trajectories of patient (reported) outcomes: the PROFILES registry. J Natl Cancer Inst. 2022;114(6):800–7.
    1. Lousberg R, Van Breukelen GJP, Groenman NH, Schmidt AJM, Arntz A, Winter FAM. Psychometric properties of the Multidimensional Pain Inventory, Dutch language version (MPI-DLV) Behav Res Ther. 1999;37(2):167–182.
    1. Kerns RD, Turk DC, Rudy TE. The West Haven-Yale Multidimensional Pain Inventory (WHYMPI) Pain. 1985;23(4):345–356.
    1. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–376.
    1. Postma TJ, Aaronson NK, Heimans JJ, Muller MJ, Hildebrand JG, Delattre JY, et al. The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20. Eur J Cancer. 2005;41(8):1135–1139.
    1. Smith EML, Barton DL, Qin R, Steen PD, Aaronson NK, Loprinzi CL. Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire. Qual Life Res. 2013;22(10):2787–2799.
    1. Dworkin RRH, Turk DDCD, Farrar JTJ, Pain JH-, 2005 U. Haythornthwaite JA, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005;113(1):9–19.
    1. Hjermstad MJ, Fayers PM, Haugen DF, Caraceni A, Hanks GW, Loge JH, et al. Studies comparing numerical rating scales, verbal rating scales, and visual analogue scales for assessment of pain intensity in adults: a systematic literature review. J Pain Symptom Manage. 2011;41(6):1073–1093.
    1. Spinhoven PH, Ormel J, Sloekers PPA, Kempen GIJM, Speckens AEM, Van Hemert AM. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med. 1997;27:363–370.
    1. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–370.
    1. Sullivan MJL, Bishop SR, Pivik J. The pain catastrophizing scale: development and validation. Psychol Assess. 1995;7(4):524–532.
    1. Wicksell RK, Olsson GL, Hayes SC. Psychological flexibility as a mediator of improvement in Acceptance and Commitment Therapy for patients with chronic pain following whiplash. Eur J Pain. 2010;14(10):1059.e1–1059.e11.
    1. Wicksell RK, Lekander M, Sorjonen K, Olsson GL. The Psychological Inflexibility in Pain Scale (PIPS) - statistical properties and model fit of an instrument to assess change processes in pain related disability. Eur J Pain. 2010;14(7):771.e1–771.e14.
    1. Trompetter HR, Bohlmeijer ET, Van Baalen B, Kleen M, Köke A, Reneman M, et al. The Psychological Inflexibility in Pain Scale (PIPS) exploration of psychometric properties in a heterogeneous chronic pain sample. Eur J Psychol Assess. 2014;30(4):289–295.
    1. Bruggeman-Everts FZ, Van der Lee ML, Van ‘t Hooft EFM, Nyklíček I. Validation of the Dutch Freiburg Mindfulness Inventory in patients with medical illness. SAGE Open. 2017;7(2):2158244017705936.
    1. Trompetter HR, Ten Klooster PM, Schreurs KMG, Fledderus M, Westerhof GJ, Bohlmeijer ET. Measuring values and committed action with the Engaged Living Scale (ELS): psychometric evaluation in a nonclinical sample and a chronic pain sample. Psychol Assess. 2013;25(4):1235–1246.
    1. Attkisson CC, Zwick R. The client satisfaction questionnaire. Psychometric properties and correlations with service utilization and psychotherapy outcome. Eval Program Plann. 1982;5(3):233–237.
    1. Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN. The self-administered comorbidity questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Care Res (Hoboken) 2003;49(2):156–163.
    1. Eysenbach G. CONSORT-EHEALTH: improving and standardizing evaluation reports of Web-based and mobile health interventions. J Med Internet Res. 2011;13:e126.
    1. Cohen J. Statistical power analysis for the behavioral sciences. 2. New Jersey: Lawrence Erlbaum; 1988.
    1. Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain. 2008;9(2):105–121.
    1. Turner JA, Holtzman S, Mancl L. Mediators, moderators, and predictors of therapeutic change in cognitive-behavioral therapy for chronic pain. Pain. 2007;127(3):276–286.
    1. Hayes A. Introduction to mediation, moderation and conditional process analysis. New York: Guilford Press; 2013.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir